Survival after cytomegalovirus pneumonia in two children receiving autologous peripheral blood progenitor cell transplantation (PBPCT)

Bone Marrow Transplantation
E CastagnolaG Dini

Abstract

Cytomegalovirus (CMV) pneumonia is a very rare but often fatal complication of autologous bone marrow or peripheral blood progenitor cell transplantation. Diagnosis is usually made by means of CMV antigenemia which is strongly predictive of CMV disease. We describe two cases of PBPC transplantation who survived after CMV pneumonia which was diagnosed only by bronchoalveolar lavage in the absence of CMV-antigenemia.

Citations

Jul 24, 2008·Bone Marrow Transplantation·E CastagnolaR Haupt
Jul 31, 2002·The Journal of Cell Biology·Sean P CreganRuth S Slack
Jan 5, 2006·Transplant Infectious Disease : an Official Journal of the Transplantation Society·F RossiniE M Pogliani
Jun 3, 2004·Human Immunology·Elio CastagnolaGiorgio Dini

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.